FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions
LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech…
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…